history of glp-1 medications Timeline critical milestones in the development and use of GLP-1-based therapies for diabetes, obesity

Chipotle Mexican Grill, one of America's biggest casual dining chains, with around 3,885 restaurants, is rolling out new menu items designed to appeal to people using GLP-1a drugs for weight loss

Most cases of cefazolin-induced DILI were classified as moderate to severe, although they were typically self-limiting [122]

Joshua Goldenberg: Mm-hmm (affirmative)

Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease

5-Amino-1MQ enhances metabolic fat oxidation without reducing hunger